rediff.com
e.g. Tata motors, Reliance MF, 500570
BSE | NSE

Sun Pharmaceutical Industries Ltd.

524715 SUNPHARMA Group (A)

16 Oct,12:04
1893.25
-4.25 (-0.22%)
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist
 
Day
Wk
Mn
6Mn
Yr
Volume Prev close Day's H/L (Rs.) 52wk H/L (Rs.) Mkt Cap (Rs. Cr)

Sun Pharmaceutical Industries Ltd.

BUYSELL

6,841 1,897.50 1,914.85 - 1,892.00 1,960.20 - 1,069.00 454,247.48
NSE | BSE

Sun Pharmaceutical Industries Ltd.

SUNPHARMA

16 Oct,12:04
1893.45
-5.00 (-0.26%)
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist
 
Day
Wk
Mn
6Mn
Yr
Volume Prev close Day's H/L (Rs.) 52wk H/L (Rs.) Turnover (Rs. Lacs)

Sun Pharmaceutical Industries Ltd.

BUYSELL

505,808 1898.45 1,914.70 - 1,891.30 1,960.35 - 1,068.35 9,627.04
(Rs. Crore)

Financial Results of Sun Pharmaceutical Industries Ltd.

Mar ' 24Mar ' 23Mar ' 22Mar ' 21Mar ' 20
Sales20,275.1720,812.1415,585.9812,803.2112,531.93
Operating profit5,587.616,472.862,907.522,936.002,711.65
Interest784.08472.18388.10256.98408.01
Gross profit5,269.296,279.713,477.342,829.243,814.56
EPS (Rs)11.917.05-0.428.9213.38

See more in Research Center »

About Sun Pharmaceutical Industries Ltd.

Sun Pharmaceutical Industries Limited (d/b/a Sun Pharma) is an Indian multinational pharmaceutical company headquartered in Mumbai, that manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients (APIs) in more than 100 countries across the globe. It is the largest pharmaceutical company in India and the fourth largest specialty generic pharmaceutical company in the world. The products cater to a vast range of therapeutic segments covering psychiatry, anti-infectives, neurology, cardiology, diabetology, gastroenterology, ophthalmology, nephrology, urology, dermatology, gynecology, respiratory, oncology, dental and nutritionals. Wikipedia

News for Pharmaceuticals and health care

South Indian Bank...
South Indian Bank Q2 Profit Up 18% to Rs 325 Cr - Business News
South Indian Bank reported an 18% increase in Q2 profit to Rs 325 crore, driven by higher income and reduced NPAs. Learn more about the bank's financial performance.
Oct 16, 2024 12:51
Wockhardt Seeks...
Wockhardt Seeks Approval for Diabetes Drug Aspart Injection
Wockhardt has filed for marketing approval of its fast-acting insulin analog, Aspart injection, with the DCGI in India. This move aims to address the growing diabetes epidemic and provide patients...
Oct 16, 2024 11:38
6G Inclusivity:...
6G Inclusivity: Scindia Calls for Affordable, Accessible Standards
India's Communications Minister Jyotiraditya Scindia emphasizes the need for inclusive and affordable 6G standards at the India Mobile Congress (IMC).
Oct 16, 2024 11:19
India's Export...
India's Export Competitiveness: Goyal Emphasizes Quality over Subsidies
Commerce Minister Piyush Goyal urges Indian industry to prioritize quality over government subsidies for export competitiveness, highlighting the importance of Quality Control Orders (QCOs) and...
Oct 16, 2024 11:12
Record Office...
Record Office Demand in India: 80 Million Sq Ft Leasing Expected in 2024
Cushman & Wakefield forecasts record office leasing in India, with gross leasing across top eight cities likely to exceed 80 million sq ft in 2024, driven by strong demand and low vacancy rates.
Oct 16, 2024 10:49

More News »

Top News

South Indian Bank...
South Indian Bank Q2 Profit Up 18% to Rs 325 Cr - Business News
South Indian Bank reported an 18% increase in Q2 profit to Rs 325 crore, driven by higher income and reduced NPAs. Learn more about the bank's financial performance.
Oct 16, 2024 12:51
Akums Drugs Inks Licensing Pact with Canadian Firm Triple Hair
Akums Drugs and Pharmaceuticals has signed a licensing agreement with Triple Hair Inc. to develop and market the Canadian firm's innovative products in India.
Oct 16, 2024 12:41
India's AI...
India's AI Advantage: Building Applications on LLMs
India emerges as a global AI hub, leveraging engineering talent and vast data to build innovative applications on top of LLMs, transforming industries like SaaS and IT services.
Oct 16, 2024 12:22
SCO Summit: Shehbaz Urges Stronger Framework to Tackle Regional Challenges
Pakistan Prime Minister Shehbaz Sharif calls for a strengthened SCO framework to address regional challenges, including poverty, climate change, and connectivity. He also highlights the importance...
Oct 16, 2024 12:20
Wockhardt Seeks...
Wockhardt Seeks Approval for Diabetes Drug Aspart Injection
Wockhardt has filed for marketing approval of its fast-acting insulin analog, Aspart injection, with the DCGI in India. This move aims to address the growing diabetes epidemic and provide patients...
Oct 16, 2024 11:38

More Top News »

Report Card

PE Ratios
159.52
EPS (Rs.)
11.91
Sales (Rs. Cr)
4,498.07
Face Value (Rs.)
1
Net Profit Margin (%)
14.09
Last Bonus
1:1
Last Dividend(%)
500
Return on Average Equity
12.06

Compare 'Sun Pharmaceutical Industries Ltd.' with other stocks

  • Dr. Reddy's Laboratories Ltd.
  • 6,664.65
  • Compare
  • Zydus Lifesciences Ltd.
  • 1,062.30
  • Compare
  • Apollo Hospitals Enterprise Ltd.
  • 7,092.70
  • Compare
  • Max Healthcare Institute Ltd.
  • 947.45
  • Compare
  • Divi's Laboratories Ltd.
  • 6,212.85
  • Compare
  • Alkem Laboratories Ltd.
  • 6,247.25
  • Compare
  • Torrent Pharmaceuticals Ltd.
  • 3,490.95
  • Compare

Most Active

  • Change (Rs.)
  •  

Sun Pharmaceutical Industries Ltd. performance snapshot

If you had invested Rs.  in Sun Pharmaceutical Industries Ltd.,     ago

You would have  Rs. 000.00 

Add to Portfolio

Peers

  • LTP
  • Change (Rs.)
  • Change %
  • Mkt Cap (Rs. Cr)
  • Volume
Close
Add Sun Pharmaceutical Industries Ltd. to your Portfolio
 
 
BSE NSE  
 
Close
Add Sun Pharmaceutical Industries Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close